{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:47Z","timestamp":1792737707118,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["NCT03561220"],"award-info":[{"award-number":["NCT03561220"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijrobp.2026.07.021","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:24:57Z","timestamp":1785367497000},"page":"1339-1344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can Engagement Aid in Design and Accrual on Clinical Trials? Observations from Comparative Study of Proton and Photon Therapy in Prostate Cancer: A Prospective Comparison of Outcomes with Proton and Photon Radiation in Prostate Cancer"],"prefix":"10.1016","volume":"126","author":[{"given":"Nancy P.","family":"Mendenhall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis M.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"DeWees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Hobkirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza Winthrop","family":"Grammel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Griggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Marckini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgil","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folakemi T.","family":"Odedina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Vapiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Curtiland","family":"Deville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Crisp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.07.021_bib0001","first-page":"439","article-title":"A critical appraisal of the clinical utility of proton therapy in oncology","volume":"8","author":"Wang","year":"2015","journal-title":"Med Devices (Auckl)."},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0002","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.6004\/jnccn.2019.7321","article-title":"Clinical trial accrual at initial course of therapy for cancer and its impact on survival","volume":"17","author":"Zaorsky","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0003","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1200\/JOP.2013.001119","article-title":"The national cancer institute-american society of clinical oncology cancer trial accrual symposium: Summary and recommendations","volume":"9","author":"Denicoff","year":"2013","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2020.100532","article-title":"Operational strategies in us cancer centers of excellence that support the successful accrual of racial and ethnic minorities in clinical trials","volume":"17","author":"Regnante","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0005","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/JU.0000000000000071","article-title":"Hypofractionated radiation therapy for localized prostate cancer: Executive summary of an ASTRO, ASCO and AUA evidence-based guideline","volume":"201","author":"Morgan","year":"2019","journal-title":"J Urol."},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0006","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/cts.13090","article-title":"What men want: Results from a national survey on decision making for prostate cancer treatment and research participation","volume":"14","author":"Mendenhall","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0007","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","article-title":"Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer","volume":"34","author":"Lee","year":"2016","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0008","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/0284186X.2021.2016948","article-title":"Five- and seven-year outcomes for image-guided moderately accelerated hypofractionated proton therapy for prostate cancer","volume":"61","author":"Henderson","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-19-00057","article-title":"Hypofractionated proton therapy in early prostate cancer: Results of a phase I\/II trial at loma linda university","volume":"6","author":"Slater","year":"2019","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ijrobp.2012.05.023","article-title":"Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"85","author":"Spratt","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0011","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2016.02.038","article-title":"Five-year biochemical results, toxicity, and patient-reported quality of life after delivery of dose-escalated image guided proton therapy for prostate cancer","volume":"95","author":"Bryant","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0012","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ijrobp.2020.11.007","article-title":"Proton therapy for localized prostate cancer: Long-term results from a single-center experience","volume":"109","author":"Takagi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0013","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.28536","article-title":"Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer","volume":"120","author":"Hoppe","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0014","first-page":"211","article-title":"Cancer statistics for African Americans, 2019","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0015","unstructured":"100 Black Men of America, Inc., 2024. Accessed May 7, 2024. https:\/\/100blackmen.org"},{"key":"10.1016\/j.ijrobp.2026.07.021_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2023.06.1635","article-title":"Prostate advanced radiation technologies investigating quality of life (partiqol): A phase III randomized clinical trial of proton therapy vs. imrt for low or intermediate risk prostate cancer","volume":"117","author":"Wisdom","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626040630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626040630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:35:45Z","timestamp":1792737345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626040630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0360301626040630"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.07.021","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can Engagement Aid in Design and Accrual on Clinical Trials? Observations from Comparative Study of Proton and Photon Therapy in Prostate Cancer: A Prospective Comparison of Outcomes with Proton and Photon Radiation in Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}